查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128446

處方VR療法市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測

Prescription VR Therapeutics Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

處方VR藥物市場成長要素

全球處方箋數位療法市場預計在2025年達到1,210萬美元，2026年成長至2,350萬美元，並在2034年達到3.713億美元，預測期內複合年成長率高達41.2%。北美市場將引領全球市場，預計到2025年將佔據93.38%的市場佔有率，這主要得益於監管部門的早期批准、先進的醫療基礎設施、強力的保險報銷政策以及處方數位療法日益普及。

處方箋虛擬實境療法是由美國食品藥物管理局 (FDA) 監管的虛擬實境 (VR) 軟體解決方案，由醫療專業人員開立處方，用於治療慢性疼痛、精神疾病、神經系統疾病、復健需求和其他疾病。與消費者導向的 VR 應用不同，這些平台經過臨床檢驗，旨在透過身臨其境型、實證療法改善患者療效。慢性病盛行率的上升、人們對非侵入性治療的日益青睞、數位醫療基礎設施的不斷擴展以及監管機構認可的提高，都在加速全球市場的成長。

市場趨勢

人工智慧（AI）驅動的個人化治療正成為處方VR治療市場最具影響力的趨勢之一。最新的VR治療平台擴大整合AI演算法、遠端監控功能和即時患者分析，以便根據患者的進展和臨床結果來個人化治療方案。

這些平台收集寶貴的患者數據，包括疼痛強度、治療順從性、症狀改善、功能恢復和患者參與。這些數據使醫療服務提供者能夠最佳化治療方案並支持以價值為導向的醫療模式。對人工智慧驅動的數位療法的投資增加以及臨床檢驗研究的擴展，正在進一步推動市場接受度。

市場促進因素

慢性病盛行率的上升是市場成長的主要驅動力。肌肉骨骼疾病、慢性疼痛、焦慮症、憂鬱症、神經系統疾病和復健治療需求的不斷成長，催生了對非侵入性數位療法的強勁需求。

以處方箋（VR）療法提供身臨其境型、無藥物治療，有助於改善疼痛管理、行為健康、復原和患者參與度。 AppliedVR、Smileyscope、Floreo 和 MindMaze 等公司持續加強研發投入，推動新產品上市，拓展治療應用，進一步促進全球市場成長。

市場限制因素

儘管成長潛力巨大，但保險報銷政策的不明確對市場擴張構成重大挑戰。處方虛擬實境療法結合了軟體、醫療設備、行為療法、遠端監測和數位治療，這使得保險報銷和承保範圍的確定更加複雜。

此外，由於治療費用包括VR頭戴裝置、軟體訂閱、患者實施支援、技術支援和持續監測，因此在沒有報銷制度的地區，患者很難獲得治療。

市場機遇

與基於價值的醫療保健和遠端患者監護相結合，蘊藏著巨大的成長機會。醫療服務提供者越來越傾向於尋求能夠展現可衡量的臨床療效，同時又能降低長期治療成本的療法。

基於處方箋的虛擬實境平台能夠持續產生患者治療數據，支援遠端監測、治療依從性追蹤、症狀評估以及個人化治療方案的最佳化。隨著醫療機構對遠端醫療監測計畫的日益重視，預計未來幾年商業性應用將加速發展。

市場挑戰

開發中國家醫療服務取得管道有限，仍是市場成長的主要障礙。許多新興經濟體仍然缺乏先進的醫療基礎設施、訓練有素的醫療專業人員、完善的報銷機制以及對數位醫療的認知。

其他挑戰包括監管複雜性、網路安全問題、病患資料隱私要求、臨床有效性檢驗以及與現有醫療保健系統的整合。儘管人們對數位療法的興趣日益濃厚，但這些因素可能會減緩發展中地區的大規模商業化進程。

細分分析

按類型：

預計到2025年，整合式處方VR治療系統細分市場將成為市場成長的主要驅動力，這主要得益於市場對集軟體、硬體、病患監測和臨床支援於一體的綜合性VR治療平台的需求不斷成長。治療軟體和內容模組預計將在預測期內實現最快成長。

按領域處理：

疼痛管理領域佔據了最大的市場佔有率，這主要得益於慢性疼痛病例的增加、整形外科手術數量的上升以及人們對非藥物疼痛管理方案日益成長的偏好。隨著虛擬實境療法在焦慮症、憂鬱症、創傷後壓力症候群（PTSD）及相關疾病治療中越來越被接受，預計心理和行為健康領域的應用將經歷最快的成長。

治療方法：

由於虛擬實境暴露療法（VRET）透過身臨其境型暴露療法有效治療焦慮症、創傷後壓力症候群（PTSD）和恐懼症，預計到2025年，VRET仍將保持其作為領先治療方法的地位。基於認知行為療法（CBT）的VR應用預計將在整個預測期內保持強勁成長。

按護理環境分類：

隨著患者越來越傾向於便利的居家治療方案，居家照護產業推動了市場的發展。遠端監控功能、個人化治療方案以及患者依從性的提高，持續推動著處方箋家庭虛擬實境療法的普及。

區域展望

北美仍然是最大的區域市場，預計到2025年將達到1,130萬美元。美國食品藥物管理局（FDA）的強力監管支持、不斷擴大的保險報銷計劃、先進的醫療基礎設施以及數位醫療的高滲透率，持續推動該地區的成長。由於處方虛擬實境療法的廣泛接受度和不斷擴大的保險覆蓋範圍，美國是最大的各國市場。

預計在預測期內，歐洲將呈現第二高的成長率。醫療保健支出不斷成長、對數位醫療的投資增加、監管政策的支持以及人們對非侵入性療法的認知不斷提高，都推動了該地區市場的擴張。

亞太地區預計將成為全球第三大區域市場。慢性病發病率上升、醫療基礎設施改善、醫療數位化發展以及中國、日本和印度等國家先進醫療技術的廣泛應用，持續創造著極具吸引力的成長機會。

在拉丁美洲、中東和非洲，預計成長將較為溫和，這主要得益於公共醫療保健投資的增加以及人們對經臨床驗證的數位療法的認知不斷提高。

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家及地區早產發生率
  • 處方虛擬實境療法的技術進步
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：全球處方VR療法市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按類型
    • 用於處方的整合式VR治療系統
    • 治療軟體和內容模組
    • 臨床管理與支援服務
  • 市場分析、洞察與預測：按治療領域分類
    • 疼痛管理
    • 心理和行為健康
    • 神經系統和認知障礙
    • 復健和功能恢復
    • 其他
  • 市場分析、洞察與預測：按治療方法分類
    • 虛擬實境暴露療法（VRET）
    • 認知行為治療（CBT）
    • 其他
  • 市場分析、洞察與預測：按護理環境分類
    • 醫院
    • 專科診所
    • 居家照護環境
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美處方VR治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲處方虛擬實境療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區處方虛擬實境療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲處方VR療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲處方VR療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • AppliedVR, Inc.
    • Smileyscope
    • Floreo
    • Mindmaze SA
    • HypnoVR
    • BiPSEE Inc.
    • Sana Health Inc
    • Rocket VR Health
    • C2CARE
Product Code: FBI117733

Growth Factors of prescription VR therapeutics Market

The global prescription VR therapeutics market was valued at USD 12.1 million in 2025 and is projected to grow from USD 23.5 million in 2026 to USD 371.3 million by 2034, registering a remarkable CAGR of 41.2% during the forecast period. North America dominated the global market with a 93.38% market share in 2025, driven by early regulatory approvals, advanced healthcare infrastructure, strong reimbursement initiatives, and increasing adoption of prescription digital therapeutics.

Prescription VR therapeutics are FDA-regulated virtual reality software solutions prescribed by healthcare professionals to treat chronic pain, mental health disorders, neurological conditions, rehabilitation needs, and other medical conditions. Unlike consumer VR applications, these platforms are clinically validated and designed to improve patient outcomes through immersive, evidence-based therapies. Rising prevalence of chronic diseases, increasing preference for non-invasive treatment methods, expanding digital healthcare infrastructure, and growing regulatory acceptance are accelerating market expansion worldwide.

Market Trends

Artificial intelligence-enabled personalization is emerging as one of the most influential trends in the prescription VR therapeutics market. Modern VR therapeutic platforms increasingly integrate AI algorithms, remote monitoring capabilities, and real-time patient analytics to personalize treatment sessions according to patient progress and clinical outcomes.

These platforms collect valuable patient data, including pain intensity, therapy adherence, symptom improvement, functional recovery, and engagement levels. Such data enables healthcare providers to optimize treatment plans while supporting value-based healthcare models. Growing investments in AI-driven digital therapeutics and expanding clinical validation studies continue to strengthen market adoption.

Market Drivers

The rising prevalence of chronic diseases is the primary factor driving market growth. Increasing cases of musculoskeletal disorders, chronic pain, anxiety, depression, neurological disorders, and rehabilitation needs are creating strong demand for non-invasive digital treatment alternatives.

Prescription VR therapeutics provide immersive therapy without medication dependency, helping improve pain management, behavioral health, rehabilitation, and patient engagement. Continuous investments in research and development by companies such as AppliedVR, Smileyscope, Floreo, and MindMaze are leading to new product launches and expanding therapeutic applications, further supporting global market growth.

Market Restraints

Despite strong growth potential, uncertain reimbursement policies remain a major challenge for market expansion. Prescription VR therapies combine software, medical devices, behavioral therapy, remote monitoring, and digital therapeutics, making reimbursement and insurance coverage more complex.

In addition, treatment costs include VR headsets, software subscriptions, patient onboarding, technical support, and continuous monitoring, limiting accessibility for patients in regions where reimbursement frameworks remain underdeveloped.

Market Opportunities

Integration with value-based healthcare and remote patient monitoring presents substantial growth opportunities. Healthcare providers increasingly seek therapies capable of demonstrating measurable clinical outcomes while reducing long-term treatment costs.

Prescription VR platforms generate continuous patient performance data that supports remote monitoring, therapy adherence tracking, symptom evaluation, and personalized treatment optimization. Growing recognition of remote therapeutic monitoring programs by healthcare authorities is expected to accelerate commercial adoption over the coming years.

Market Challenges

Limited healthcare access across developing countries remains one of the key barriers to market growth. Many emerging economies continue to face shortages of advanced healthcare infrastructure, trained healthcare professionals, reimbursement mechanisms, and digital health awareness.

Additional challenges include regulatory complexities, cybersecurity concerns, patient data privacy requirements, clinical validation, and integration with existing healthcare systems. These factors may slow large-scale commercialization in developing regions despite growing interest in digital therapeutics.

Segmentation Analysis

By Type:

The integrated prescription VR therapeutic systems segment dominated the market in 2025 due to increasing demand for comprehensive VR treatment platforms combining software, hardware, patient monitoring, and clinical support. Therapeutic software and content modules are expected to register the fastest growth during the forecast period.

By Therapeutic Area:

The pain management segment accounted for the largest market share, supported by rising chronic pain cases, increasing orthopedic surgeries, and growing preference for drug-free pain management solutions. Mental and behavioral health applications are projected to experience the fastest growth as VR therapy becomes increasingly accepted for anxiety, depression, PTSD, and related disorders.

By Therapeutic Approach:

Virtual Reality Exposure Therapy (VRET) remained the leading therapeutic approach in 2025 due to its effectiveness in treating anxiety disorders, PTSD, and phobias through immersive exposure-based treatment. Cognitive Behavioral Therapy (CBT)-based VR applications are expected to witness strong growth throughout the forecast period.

By Care Setting:

The homecare settings segment dominated the market as patients increasingly prefer convenient home-based treatment solutions. Remote monitoring capabilities, personalized therapy sessions, and improved patient adherence continue supporting widespread adoption of home-based prescription VR therapeutics.

Regional Outlook

North America remained the largest regional market, reaching USD 11.3 million in 2025. Strong FDA regulatory support, growing reimbursement initiatives, advanced healthcare infrastructure, and high digital health adoption continue driving regional growth. The U.S. represents the largest national market owing to widespread acceptance of prescription VR therapy and increasing insurance coverage.

Europe is expected to witness the second-fastest growth during the forecast period. Rising healthcare expenditure, increasing digital healthcare investments, supportive regulatory initiatives, and growing awareness of non-invasive therapies are contributing to regional market expansion.

Asia Pacific is projected to emerge as the third-largest regional market. Rising chronic disease prevalence, improving healthcare infrastructure, increasing healthcare digitization, and expanding adoption of advanced medical technologies in countries such as China, Japan, and India continue creating attractive growth opportunities.

Latin America and the Middle East & Africa are expected to record moderate growth as public healthcare investments increase and awareness regarding clinically validated digital therapeutics continues to improve.

Competitive Landscape

The global prescription VR therapeutics market remains relatively concentrated, led by AppliedVR, Inc., Smileyscope, Floreo, MindMaze SA, HypnoVR, BiPSEE Inc., Sana Health Inc., Rocket VR Health, and C2CARE. Leading companies are focusing on FDA approvals, insurance reimbursement, AI-powered therapy personalization, strategic partnerships, mergers and acquisitions, and clinical research to strengthen their competitive positions. Continuous innovation in immersive therapeutic technologies and expanding evidence-based treatment programs are expected to intensify market competition throughout the forecast period.

Conclusion

The global prescription VR therapeutics market is poised for exceptional growth through 2034, driven by increasing adoption of non-invasive digital healthcare solutions, rising chronic disease burden, and expanding regulatory acceptance of virtual reality-based treatments. Strong technological advancements in artificial intelligence, personalized therapy, remote patient monitoring, and value-based healthcare models are expected to transform patient care across multiple therapeutic areas. Although reimbursement limitations and healthcare accessibility challenges remain, ongoing clinical validation, regulatory approvals, and growing investments by healthcare providers and technology companies are expected to sustain long-term market expansion.

Segmentation By Type, Therapeutic Area, Therapeutic Approach, Care Setting, and Region

By Type * Integrated Prescription VR Therapeutic Systems

  • Therapeutic Software & Content Modules
  • Clinical Management & Support Services

By Therapeutic Area * Pain Management

  • Mental & Behavioral Health
  • Neurological & Cognitive Disorders
  • Rehabilitation & Functional Recovery
  • Others

By Therapeutic Approach * Virtual Reality Exposure Therapy (VRET)

  • Cognitive Behavioral Therapy (CBT)
  • Others

By Care Setting * Hospitals

  • Specialty Clinics
  • Homecare Settings
  • Others

By Region * North America (By Type, By Therapeutic Area, By Therapeutic Approach, By Care Setting, and by Country)

    • U.S. (By Type)
    • Canada (By Type)
  • Europe (By Type, By Therapeutic Area, By Therapeutic Approach, By Care Setting, and by Country/Sub-region)
    • U.K. (By Type)
    • Germany (By Type)
    • France (By Type)
    • Italy (By Type)
    • Spain (By Type)
    • Scandinavia (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By Type, By Therapeutic Area, By Therapeutic Approach, By Care Setting, and by Country/Sub-region)
    • China (By Type)
    • Japan (By Type)
    • India (By Type)
    • Australia (By Type)
    • Southeast Asia (By Type)
    • Rest of Asia Pacific (By Type)
  • Latin America (By Type, By Therapeutic Area, By Therapeutic Approach, By Care Setting, and by Country/Sub-region)
    • Brazil (By Type)
    • Mexico (By Type)
    • Rest of Latin America (By Type)
  • Middle East & Africa (By Type, By Therapeutic Area, By Therapeutic Approach, By Care Setting, and by Country/Sub-region)
    • GCC (By Type)
    • South Africa (By Type)
    • Rest of the Middle East & Africa (By Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Preterm Births, Key Countries/Regions, 2025
  • 4.2. Technological Advancements in Prescription VR Therapeutics
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Prescription VR Therapeutics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Integrated Prescription VR Therapeutic Systems
    • 5.1.2. Therapeutic Software & Content Modules
    • 5.1.3. Clinical Management & Support Services
  • 5.2. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 5.2.1. Pain Management
    • 5.2.2. Mental & Behavioral Health
    • 5.2.3. Neurological & Cognitive Disorders
    • 5.2.4. Rehabilitation & Functional Recovery
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Therapeutic Approach
    • 5.3.1. Virtual Reality Exposure Therapy (VRET)
    • 5.3.2. Cognitive Behavioral Therapy (CBT)
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Care Setting
    • 5.4.1. Hospitals
    • 5.4.2. Specialty Clinics
    • 5.4.3. Homecare Settings
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Prescription VR Therapeutics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Integrated Prescription VR Therapeutic Systems
    • 6.1.2. Therapeutic Software & Content Modules
    • 6.1.3. Clinical Management & Support Services
  • 6.2. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 6.2.1. Pain Management
    • 6.2.2. Mental & Behavioral Health
    • 6.2.3. Neurological & Cognitive Disorders
    • 6.2.4. Rehabilitation & Functional Recovery
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Therapeutic Approach
    • 6.3.1. Virtual Reality Exposure Therapy (VRET)
    • 6.3.2. Cognitive Behavioral Therapy (CBT)
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Care Setting
    • 6.4.1. Hospitals
    • 6.4.2. Specialty Clinics
    • 6.4.3. Homecare Settings
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Type
    • 6.5.2. Canada
      • 6.5.2.1. By Type

7. Europe Prescription VR Therapeutics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Integrated Prescription VR Therapeutic Systems
    • 7.1.2. Therapeutic Software & Content Modules
    • 7.1.3. Clinical Management & Support Services
  • 7.2. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 7.2.1. Pain Management
    • 7.2.2. Mental & Behavioral Health
    • 7.2.3. Neurological & Cognitive Disorders
    • 7.2.4. Rehabilitation & Functional Recovery
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Therapeutic Approach
    • 7.3.1. Virtual Reality Exposure Therapy (VRET)
    • 7.3.2. Cognitive Behavioral Therapy (CBT)
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Care Setting
    • 7.4.1. Hospitals
    • 7.4.2. Specialty Clinics
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Type
    • 7.5.2. Germany
      • 7.5.2.1. By Type
    • 7.5.3. France
      • 7.5.3.1. By Type
    • 7.5.4. Spain
      • 7.5.4.1. By Type
    • 7.5.5. Italy
      • 7.5.5.1. By Type
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Type
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Type

8. Asia Pacific Prescription VR Therapeutics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Integrated Prescription VR Therapeutic Systems
    • 8.1.2. Therapeutic Software & Content Modules
    • 8.1.3. Clinical Management & Support Services
  • 8.2. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 8.2.1. Pain Management
    • 8.2.2. Mental & Behavioral Health
    • 8.2.3. Neurological & Cognitive Disorders
    • 8.2.4. Rehabilitation & Functional Recovery
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Therapeutic Approach
    • 8.3.1. Virtual Reality Exposure Therapy (VRET)
    • 8.3.2. Cognitive Behavioral Therapy (CBT)
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Care Setting
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Homecare Settings
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Type
    • 8.5.2. Australia
      • 8.5.2.1. By Type
    • 8.5.3. China
      • 8.5.3.1. By Type
    • 8.5.4. India
      • 8.5.4.1. By Type
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Type
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Type

9. Latin America Prescription VR Therapeutics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Integrated Prescription VR Therapeutic Systems
    • 9.1.2. Therapeutic Software & Content Modules
    • 9.1.3. Clinical Management & Support Services
  • 9.2. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 9.2.1. Pain Management
    • 9.2.2. Mental & Behavioral Health
    • 9.2.3. Neurological & Cognitive Disorders
    • 9.2.4. Rehabilitation & Functional Recovery
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Therapeutic Approach
    • 9.3.1. Virtual Reality Exposure Therapy (VRET)
    • 9.3.2. Cognitive Behavioral Therapy (CBT)
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Care Setting
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Homecare Settings
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Type
    • 9.5.2. Mexico
      • 9.5.2.1. By Type
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Type

10. Middle East & Africa Prescription VR Therapeutics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Integrated Prescription VR Therapeutic Systems
    • 10.1.2. Therapeutic Software & Content Modules
    • 10.1.3. Clinical Management & Support Services
  • 10.2. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 10.2.1. Pain Management
    • 10.2.2. Mental & Behavioral Health
    • 10.2.3. Neurological & Cognitive Disorders
    • 10.2.4. Rehabilitation & Functional Recovery
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Therapeutic Approach
    • 10.3.1. Virtual Reality Exposure Therapy (VRET)
    • 10.3.2. Cognitive Behavioral Therapy (CBT)
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Care Setting
    • 10.4.1. Hospitals
    • 10.4.2. Specialty Clinics
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Type
    • 10.5.2. South Africa
      • 10.5.2.1. By Type
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. AppliedVR, Inc.
    • 11.2.2. Smileyscope
    • 11.2.3. Floreo
    • 11.2.4. Mindmaze SA
    • 11.2.5. HypnoVR
    • 11.2.6. BiPSEE Inc.
    • 11.2.7. Sana Health Inc
    • 11.2.8. Rocket VR Health
    • 11.2.9. C2CARE

List of Tables

  • Table 1: Global Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 2: Global Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Area, 2021-2034
  • Table 3: Global Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Approach, 2021-2034
  • Table 4: Global Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Care Setting, 2021-2034
  • Table 5: Global Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 7: North America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Area, 2021-2034
  • Table 8: North America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Approach, 2021-2034
  • Table 9: North America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Care Setting, 2021-2034
  • Table 10: North America Prescription VR Therapeutics Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: U.S. Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 12: Canada Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 13: Europe Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 14: Europe Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Area, 2021-2034
  • Table 15: Europe Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Approach, 2021-2034
  • Table 16: Europe Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Care Setting, 2021-2034
  • Table 17: Europe Prescription VR Therapeutics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Germany Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 19: U.K. Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 20: France Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 21: Italy Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 22: Spain Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 23: Scandinavia Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 24: Rest of Europe Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 25: Asia Pacific Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 26: Asia Pacific Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Area, 2021-2034
  • Table 27: Asia Pacific Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Approach, 2021-2034
  • Table 28: Asia Pacific Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Care Setting, 2021-2034
  • Table 29: Asia Pacific Prescription VR Therapeutics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: China Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 31: Japan Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 32: India Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 33: Australia Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 34: Southeast Asia Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 35: Rest of Asia Pacific Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 36: Latin America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 37: Latin America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Area, 2021-2034
  • Table 38: Latin America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Approach, 2021-2034
  • Table 39: Latin America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Care Setting, 2021-2034
  • Table 40: Latin America Prescription VR Therapeutics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 42: Mexico Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 43: Rest of Latin America Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 44: Middle East & Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 45: Middle East & Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Area, 2021-2034
  • Table 46: Middle East & Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Therapeutic Approach, 2021-2034
  • Table 47: Middle East & Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Care Setting, 2021-2034
  • Table 48: Middle East & Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 50: South Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 51: Rest of Middle East & Africa Prescription VR Therapeutics Market Revenue (USD million) Forecast, by Type, 2021-2034

List of Figures

  • Figure 1: Global Prescription VR Therapeutics Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Prescription VR Therapeutics Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Prescription VR Therapeutics Market Value Share (%), by Therapeutic Area, 2025 & 2034
  • Figure 4: Global Prescription VR Therapeutics Market Value Share (%), by Therapeutic Approach, 2025 & 2034
  • Figure 5: Global Prescription VR Therapeutics Market Value Share (%), by Care Setting, 2025 & 2034
  • Figure 6: Global Prescription VR Therapeutics Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Prescription VR Therapeutics Market Value (USD million), by Type, 2025 & 2034
  • Figure 8: North America Prescription VR Therapeutics Market Value Share (%), by Type, 2025
  • Figure 9: North America Prescription VR Therapeutics Market Value (USD million), by Therapeutic Area, 2025 & 2034
  • Figure 10: North America Prescription VR Therapeutics Market Value Share (%), by Therapeutic Area, 2025
  • Figure 11: North America Prescription VR Therapeutics Market Value (USD million), by Therapeutic Approach, 2025 & 2034
  • Figure 12: North America Prescription VR Therapeutics Market Value Share (%), by Therapeutic Approach, 2025
  • Figure 13: North America Prescription VR Therapeutics Market Value (USD million), by Care Setting, 2025 & 2034
  • Figure 14: North America Prescription VR Therapeutics Market Value Share (%), by Care Setting, 2025
  • Figure 15: North America Prescription VR Therapeutics Market Value (USD million), By Country, 2025 & 2034
  • Figure 16: North America Prescription VR Therapeutics Market Value Share (%), By Country, 2025
  • Figure 17: Europe Prescription VR Therapeutics Market Value (USD million), by Type, 2025 & 2034
  • Figure 18: Europe Prescription VR Therapeutics Market Value Share (%), by Type, 2025
  • Figure 19: Europe Prescription VR Therapeutics Market Value (USD million), by Therapeutic Area, 2025 & 2034
  • Figure 20: Europe Prescription VR Therapeutics Market Value Share (%), by Therapeutic Area, 2025
  • Figure 21: Europe Prescription VR Therapeutics Market Value (USD million), by Therapeutic Approach, 2025 & 2034
  • Figure 22: Europe Prescription VR Therapeutics Market Value Share (%), by Therapeutic Approach, 2025
  • Figure 23: Europe Prescription VR Therapeutics Market Value (USD million), by Care Setting, 2025 & 2034
  • Figure 24: Europe Prescription VR Therapeutics Market Value Share (%), by Care Setting, 2025
  • Figure 25: Europe Prescription VR Therapeutics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Prescription VR Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Prescription VR Therapeutics Market Value (USD million), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Prescription VR Therapeutics Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Prescription VR Therapeutics Market Value (USD million), by Therapeutic Area, 2025 & 2034
  • Figure 30: Asia Pacific Prescription VR Therapeutics Market Value Share (%), by Therapeutic Area, 2025
  • Figure 31: Asia Pacific Prescription VR Therapeutics Market Value (USD million), by Therapeutic Approach, 2025 & 2034
  • Figure 32: Asia Pacific Prescription VR Therapeutics Market Value Share (%), by Therapeutic Approach, 2025
  • Figure 33: Asia Pacific Prescription VR Therapeutics Market Value (USD million), by Care Setting, 2025 & 2034
  • Figure 34: Asia Pacific Prescription VR Therapeutics Market Value Share (%), by Care Setting, 2025
  • Figure 35: Asia Pacific Prescription VR Therapeutics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Prescription VR Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Prescription VR Therapeutics Market Value (USD million), by Type, 2025 & 2034
  • Figure 38: Latin America Prescription VR Therapeutics Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Prescription VR Therapeutics Market Value (USD million), by Therapeutic Area, 2025 & 2034
  • Figure 40: Latin America Prescription VR Therapeutics Market Value Share (%), by Therapeutic Area, 2025
  • Figure 41: Latin America Prescription VR Therapeutics Market Value (USD million), by Therapeutic Approach, 2025 & 2034
  • Figure 42: Latin America Prescription VR Therapeutics Market Value Share (%), by Therapeutic Approach, 2025
  • Figure 43: Latin America Prescription VR Therapeutics Market Value (USD million), by Care Setting, 2025 & 2034
  • Figure 44: Latin America Prescription VR Therapeutics Market Value Share (%), by Care Setting, 2025
  • Figure 45: Latin America Prescription VR Therapeutics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Prescription VR Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Prescription VR Therapeutics Market Value (USD million), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Prescription VR Therapeutics Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Prescription VR Therapeutics Market Value (USD million), by Therapeutic Area, 2025 & 2034
  • Figure 50: Middle East & Africa Prescription VR Therapeutics Market Value Share (%), by Therapeutic Area, 2025
  • Figure 51: Middle East & Africa Prescription VR Therapeutics Market Value (USD million), by Therapeutic Approach, 2025 & 2034
  • Figure 52: Middle East & Africa Prescription VR Therapeutics Market Value Share (%), by Therapeutic Approach, 2025
  • Figure 53: Middle East & Africa Prescription VR Therapeutics Market Value (USD million), by Care Setting, 2025 & 2034
  • Figure 54: Middle East & Africa Prescription VR Therapeutics Market Value Share (%), by Care Setting, 2025
  • Figure 55: Middle East & Africa Prescription VR Therapeutics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Prescription VR Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Prescription VR Therapeutics Market Share (%), By Company, 2025